Ramirez-Sandoval, Juan Carlos http://orcid.org/0000-0002-2735-2941
Marino, Lluvia
Cojuc-Konigsberg, Gabriel
Reul-Linares, Estefania
Pichardo-Cabrera, Nathalie Desire
Cruz, Cristino
Hernández-Paredes, Elisa Naomi
Berman-Parks, Nathan
Vidal-Ruíz, Vanessa
Estrada-Linares, Jonathan Mauricio
Reza-Albarrán, Alfredo Adolfo
Correa-Rotter, Ricardo
Morales-Buenrostro, Luis Eduardo
Article History
Received: 4 June 2023
Accepted: 19 October 2023
First Online: 30 November 2023
Declarations
:
: The results presented in this paper have not been published previously. The authors of this paper declare that the paper is original, is not plagiarized, is submitted for first publication in this journal, and has not been published or submitted for publication elsewhere, and that there is no affiliation with any organization with a direct or indirect financial interest in the subject matter discussed in the manuscript that may affect the reporting of the article submitted. No pharmaceutical or biotechnology company, foundation, or any other source participated in the design, monitoring, data collection, and analysis. Dr. Juan Carlos Ramírez-Sandoval is a member of the Review Board of Frontiers in medicine, has received honoraria from Bayer México, and has lectured for Abbvie, Amgen, Synthom, Bayer, and AstraZeneca. Dr. Ricardo Correa-Rotter is a member of the Review Board of Blood Purification, has received honoraria as consultant from AbbVie, AstraZeneca, GlaxoSmithKline, Bayer, and Boehringer Ingelheim, participates in research from: Boehringer Ingelheim, Baxter, AstraZeneca and has lectured for Amgen, AstraZeneca, Bayer, Boehringer Ingelheim and Sanofi. Luis E. Morales-Buenrostro has received honoraria from AstraZeneca, Boehringer Ingelheim, Sanofi, Asofarma, and Roche. Lluvia Marino Gabriel Cojuc-Konigsberg, Estefania Reul-Linares, Nathalie Desire Pichardo-Cabrera, Cristino Cruz, Elisa Naomi Hernández-Paredes, Nathan Berman-Parks, Vanesa Vidal Ruiz, Jonathan Mauricio Estrada Linares, and Alfredo A. Reza-Albarrán have no competing interest to declare.
: This study was approved by the local Human Research and Ethics Boards (NMM-4220-22-23-1) and adhered to the principles outlined in the 1964 Helsinki Declaration and its subsequent amendments.
: This study does not contain any studies with animals performed by any of the authors.
: Participants who underwent biomarker assessment provided informed consent.